What is going on at the Center for Endocrinology, Diabetes and Metabolism, at Children’s Hospital Los Angeles (CHLA)? A very exciting development that might be useful to some of our readers, or to someone they know in Southern California. So please feel free to share the tweet shown at the top of this page. If you have a child or know a child who needs this help, here is the link to go to for more information and the application procedure.
This upcoming interventional study has two titles: the long one is “An Addiction Model Based Mobile Health Weight Loss Intervention With Coaching in Adolescents With Overweight and Obesity: Multi-Site Randomized Controlled Trial,” and the shorter version is “An Addiction-Based Mobile Health Weight Loss Intervention With Coaching.”
These are the bare-bones details:
Purpose of Research:
To test the effectiveness of an addiction-based weight loss intervention, embodied first as a smartphone app with telephone coaching (AppCoach) compared to (1) addiction model based weight-loss app alone (App) and (2) multi-disciplinary in-clinic weight loss intervention (Clinic) on weight outcomes of overweight and obese adolescents at 3, 6, 12 and 18 months post enrollment.Eligibility:
1. Age 14-18 years 2. Able to read English 3. Body mass index [BMI] ≥85th percentile for age and genderTime Commitment/Requirements:
18 months: group 1 and 2: 5 visits group 3: 9 visits Compensation provided.
Here is a roundup of the coverage so far, of this series of studies:
- This post describes the first true independent study of the app with an outside group.
- This page from the National Institutes of Health tells how the preliminary study came out.
- This post talks about Dr. Pretlow’s publication in the journal Pediatric Obesity, of the article titled “An addiction model-based mobile health weight loss intervention in adolescents with obesity.”
Next, we noted Dr. Pretlow’s speech given at CHLA last August, saying…
The randomized controlled trial will continue for three years, which is quite a respectable length of time for a study, with a nice number of subjects, too — 180 overweight adolescents participating through four or possibly five institutions.
This next set of posts covered some of the individuals involved in this large and complicated endeavor. Dr. Steven Mittelman is a pediatric endocrinologist who investigates, among other things, the relationship between obesity and cancer, under the auspices of the Diabetes and Obesity Program at CHLA.
And now, other professionals lending their talents and expertise:
- Alaina Vidmar, M.D. (Primary Investigator for the new study)
- Claudia Borzutzky, M.D.
- Sarah-Jeanne Salvy, Ph.D.
- Suzette Glasner-Edwards, Ph.D.
Other related articles are: “Saban Institute Shares Research News” and “Diabetes and Obesity at CHLA.”
Your responses and feedback are welcome!
Source: “CHLA Clinical Research Studies,” CHLA.org
Image by CHLA on Twitter
FAQs and Media Requests: 
